Skip to content

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

Identifying Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway in Patients With Congenital Malformations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03799705
Enrollment
132
Registered
2019-01-10
Start date
2019-12-01
Completion date
2022-12-01
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Malformation, Vacterl Association

Brief summary

Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults with confirmed or putative diagnosis of VACTERL association; 2. Families (mother, father, biological offspring) with a history of VACTERL-associated malformations 3. Gravid or non-gravid women with a history of miscarriage and/or offspring with non-VACTERL-associated malformations 4. Willingness to abstain from red meat, meat products, chicken, peanuts, or brewer's yeast (including beer) at least 24 hours prior to blood and urine collection

Exclusion criteria

1\) Parents of non-biological children 3) Children with congenital malformations associated with an identifiable environmental or lifestyle exposure 4) Children with congenital malformations associated with confirmed chromosomal disorders 5) Failure to abstain from red meat, meat products, chicken, peanuts, or brewer's yeast (including beer) at least 24 hours prior to blood and urine collection.

Design outcomes

Primary

MeasureTime frameDescription
Genetic variants2 yearsIdentification of genetic variants which may be associated with VACTERL association or other congenital malformations.
Targeted metabolomics2 yearsIdentification of changes in metabolic pathways which may provide functional insight into the presence of genetic variants in patients with VACTERL association

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026